Source: Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Helen White, Nicola Shaw, Sarah Denman, Kim Pollard, Sarah Wynne, Daniel Gavin Peckham. Variation in lung function as a marker of adherence to oral and inhaled medication in cystic fibrosis. Eur Respir J , 49 (3) 1600987; DOI: 10.1183/13993003.00987-2016

Member's Comments

No comment yet.

Related content which might interest you: Inhaled corticosteroids and lower lung function decline in young children with cystic fibrosis Source: Eur Respir J 2011; 37: 1091-1095 Year: 2011 Ataluren in nonsense mutation cystic fibrosis patients not receiving chronic inhaled tobramycin: Evaluation of exacerbations and lung function Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring Year: 2016 Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis Source: Eur Respir J 2002; 20: 122-126 Year: 2002 Recommended shielding against SARS-CoV-2 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Efficacy and safety of oral sildenafil in cystic fibrosis childrenwith mild to moderate lung disease Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 Combination of inhaled corticosteroids and long acting beta two agonists improve lung clearance index (LCI) in preschoolers with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Optimising inhaled mannitol for cystic fibrosis in an adult population Source: Breathe 2015; 11:39-48 Year: 2015 Lung function parameters influence serum concentration after antibiotic inhalation in patients with cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 537s Year: 2001 RhDNase after airway clearance therapy improves peripheral airway patency in children with cystic fibrosis Source: Annual Congress 2006 - Cystic fibrosis lung disease: molecules images and drugs Year: 2006 The influence of dornase alfa on long-term lung function in cystic fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 538s Year: 2001 The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007 Lung clearance index improves with treatment of an exacerbation in cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage Year: 2007 Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 342s Year: 2002 Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis Source: Eur Respir J 2002; 19: 294-302 Year: 2002 The pharmacogenomics of inhaled corticosteroids and lung function decline in COPD Source: Eur Respir J, 54 (6) 1900521; 10.1183/13993003.00521-2019 Year: 2019 Effect of dupilumab on oral corticosteroid use in severe asthma patients with improving lung function Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Lack of therapeutic potential for topical metformin in treatment of airway secretion dehydration in cystic fibrosis Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease Year: 2009 Improving airway clearance in cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 169-187 Year: 2014 Pulmonary function test changes after cessation of inhaled corticosteroid therapy in asthma patients Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012